Literature DB >> 29145789

Helicobacter pylori controls NLRP3 expression by regulating hsa-miR-223-3p and IL-10 in cultured and primary human immune cells.

Suneesh Kumar Pachathundikandi1, Steffen Backert1.   

Abstract

Inflammasome-mediated production of mature IL-1β and IL-18 cytokines represents an important innate immune response against infecting pathogens. Helicobacter pylori, one of the most successful and persistent human pathogens, induces severe inflammation leading to gastritis and more serious gastric diseases. H. pylori modulates different immune responses for its survival and inflammasome signaling is manipulated by the cag pathogenicity island ( cagPAI), urease and VacA cytotoxin. Here we report that H. pylori regulates NLRP3 expression, an inflammasome forming regulator, in infected THP-1 monocytes. This response was independent of the major H. pylori pathogenicity-associated factors CagA, VacA, Cgt, FlaA and cagPAI. Two NLRP3 expression controlling factors, the NLRP3 mRNA targeting microRNA hsa-miR-223-3p and cytokine IL-10, were found to work in tandem for its regulation. H. pylori infection also induced copious amount of pro-IL-1β in THP-1 monocytes/macrophages but secreted a very low amount of mature IL-1β. Moreover, secreted IL-10 correlated with the down-regulation of nigericin-induced NLRP3 inflammasome activation of LPS-primed THP-1 monocytes and human PBMCs from volunteers. However, H. pylori-treated PBMCs secreted significantly more mature IL-1β throughout the infection period, which suggests a different mode of activation. Taken together, this study demonstrates targeting of inflammasome-forming NLRP3, an important innate immunity component, and crucial manipulation of pro- and anti-inflammatory cytokines in H. pylori infection.

Entities:  

Keywords:  H. pylori; Inflammasome; NLRP3; interleukin-10; interleukin-1β; miRNA

Mesh:

Substances:

Year:  2017        PMID: 29145789      PMCID: PMC6830764          DOI: 10.1177/1753425917738043

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  64 in total

1.  Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin-integrin linked kinase signalling complex.

Authors:  Tobias Wiedemann; Stefan Hofbaur; Nicole Tegtmeyer; Sylwia Huber; Norbert Sewald; Silja Wessler; Steffen Backert; Gabriele Rieder
Journal:  Gut       Date:  2012-01-27       Impact factor: 23.059

2.  The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock.

Authors:  Wei Shao; Garabet Yeretssian; Karine Doiron; Sabah N Hussain; Maya Saleh
Journal:  J Biol Chem       Date:  2007-10-24       Impact factor: 5.157

3.  Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia.

Authors:  Mikhail A Gavrilin; Dalia H A Abdelaziz; Mahmoud Mostafa; Basant A Abdulrahman; Jaykumar Grandhi; Anwari Akhter; Arwa Abu Khweek; Daniel F Aubert; Miguel A Valvano; Mark D Wewers; Amal O Amer
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

4.  c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains.

Authors:  Doreen Mueller; Nicole Tegtmeyer; Sabine Brandt; Yoshio Yamaoka; Eimear De Poire; Dionyssios Sgouras; Silja Wessler; Javier Torres; Adam Smolka; Steffen Backert
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 5.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.

Authors:  Ron N Apte; Shahar Dotan; Moshe Elkabets; Malka R White; Eli Reich; Yaron Carmi; Xiaping Song; Tatyana Dvozkin; Yakov Krelin; Elena Voronov
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

6.  Helicobacter pylori induce neutrophil transendothelial migration: role of the bacterial HP-NAP.

Authors:  Mikael Brisslert; Karin Enarsson; Samuel Lundin; Anna Karlsson; Johannes G Kusters; Ann-Mari Svennerholm; Steffen Backert; Marianne Quiding-Järbrink
Journal:  FEMS Microbiol Lett       Date:  2005-08-01       Impact factor: 2.742

7.  Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18.

Authors:  Daniela B Engler; Irina Leonardi; Mara L Hartung; Andreas Kyburz; Sabine Spath; Burkhard Becher; Gerhard Rogler; Anne Müller
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

Review 8.  Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system.

Authors:  Steffen Backert; Nicole Tegtmeyer; Wolfgang Fischer
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 9.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

10.  Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome.

Authors:  Viola Neudecker; Moritz Haneklaus; Owen Jensen; Ludmila Khailova; Joanne C Masterson; Hazel Tye; Kathryn Biette; Paul Jedlicka; Kelley S Brodsky; Mark E Gerich; Matthias Mack; Avril A B Robertson; Matthew A Cooper; Glenn T Furuta; Charles A Dinarello; Luke A O'Neill; Holger K Eltzschig; Seth L Masters; Eóin N McNamee
Journal:  J Exp Med       Date:  2017-05-09       Impact factor: 14.307

View more
  9 in total

Review 1.  Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion.

Authors:  Daniel Sijmons; Andrew J Guy; Anna K Walduck; Paul A Ramsland
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

2.  MiR-223-3p inhibits inflammation and pyroptosis in monosodium urate-induced rats and fibroblast-like synoviocytes by targeting NLRP3.

Authors:  J Tian; D Zhou; L Xiang; X Liu; H Zhang; B Wang; B Xie
Journal:  Clin Exp Immunol       Date:  2021-03-09       Impact factor: 5.732

3.  Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis.

Authors:  Olivier Fogel; Andreas Bugge Tinggaard; Maud Fagny; Nelly Sigrist; Elodie Roche; Laurence Leclere; Jean-François Deleuze; Frederic Batteux; Maxime Dougados; Corinne Miceli-Richard; Jörg Tost
Journal:  Arthritis Res Ther       Date:  2019-02-12       Impact factor: 5.156

4.  Apoptosis inhibitor of macrophage (AIM) contributes to IL-10-induced anti-inflammatory response through inhibition of inflammasome activation.

Authors:  Tae-Hyun Kim; Kyungwon Yang; Minsuk Kim; Hee-Sun Kim; Jihee Lee Kang
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

Review 5.  The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges.

Authors:  Fan Zhang; Yunxin Zhou; Junying Ding
Journal:  Cell Mol Biol Lett       Date:  2022-08-19       Impact factor: 8.702

Review 6.  Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer.

Authors:  Andreea Ligia Dincă; Lorena Elena Meliț; Cristina Oana Mărginean
Journal:  Children (Basel)       Date:  2022-07-20

7.  Helicobacter pylori Avoids the Critical Activation of NLRP3 Inflammasome-Mediated Production of Oncogenic Mature IL-1β in Human Immune Cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Blaser; Heiko Bruns; Steffen Backert
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

Review 8.  Immune Response in H. pylori-Associated Gastritis and Gastric Cancer.

Authors:  Qingbin Niu; Jun Zhu; Xingquan Yu; Tao Feng; Hong Ji; Yuming Li; Weiwei Zhang; Baoguang Hu
Journal:  Gastroenterol Res Pract       Date:  2020-01-28       Impact factor: 2.260

9.  MicroRNA‑502‑3p promotes Mycobacterium tuberculosis survival in macrophages by modulating the inflammatory response by targeting ROCK1.

Authors:  Fang Liu; Zhen Dong; Yuefu Lin; Haibo Yang; Pingping Wang; Yongxia Zhang
Journal:  Mol Med Rep       Date:  2021-09-03       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.